Metoprolol Teva

Metoprolol tartrate, the active ingredient in Metoprolol Teva, is a beta blocker presented as an oral tablet for cardiovascular use. It lowers blood pressure, relieves angina, and helps control heart rhythm in adults by selectively blocking β1‑adrenergic receptors, reducing heart rate and myocardial contractility.

GNH USA supplies Metoprolol Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprolol Teva is used to manage conditions within the cardiovascular disease spectrum, particularly those involving elevated blood pressure or cardiac workload.

- Hypertension: reduces systolic and diastolic blood pressure, helping to prevent stroke and kidney damage. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain during exertion. - Post‑myocardial infarction: improves survival by lowering the risk of recurrent heart attacks. - Chronic heart failure: enhances ventricular function and reduces hospitalizations. - Cardiac arrhythmias: stabilizes heart rhythm by slowing conduction through the AV node.

Metoprolol Teva may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Fatigue or tiredness - Dizziness or light‑headedness - Bradycardia (slow heart rate) - Cold extremities - Headache - Gastrointestinal upset (nausea, abdominal discomfort)

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm, especially in patients with asthma - Allergic reactions such as rash or angioedema - Depression or mood changes

When prescribing Metoprolol Teva, clinicians should observe several precautionary measures to ensure patient safety.

- Monitor blood pressure: check regularly to avoid excessive hypotension. - Assess heart rate: ensure rate remains above safe threshold before dose adjustments. - Use caution in asthma or chronic obstructive pulmonary disease: β1 selectivity may still affect bronchial tone. - Adjust dose in renal or hepatic impairment: reduced clearance may increase drug exposure. - Avoid abrupt discontinuation: taper gradually to prevent rebound tachycardia or hypertension. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Metoprolol Teva can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Combined use with other β‑blockers: may cause excessive bradycardia. - Concomitant calcium‑channel blockers (verapamil, diltiazem): can lead to profound AV‑node depression. - Clonidine withdrawal: may precipitate severe hypertension. - MAO inhibitors: increase risk of hypertensive crisis. - Non‑selective β‑blockers: additive cardiac depression.

Moderate Interactions (Monitor Closely): - NSAIDs: may blunt antihypertensive effect. - Diuretics: increase risk of electrolyte imbalance and hypotension. - Digoxin: may enhance bradycardic effect. - Antidepressants (SSRIs, SNRIs): potential for increased heart rate variability. - Antidiabetic agents: may mask hypoglycemia symptoms.